지혈제 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 유형별, 제제별, 용도별, 지역별, 경쟁별(2020-2030년)

The Global Hemostats Market, valued at USD 3.82 Billion in 2024, is projected to experience a CAGR of 7.48% to reach USD 5.89 Billion by 2030. Hemostats are specialized medical devices or agents employed to arrest bleeding during surgical procedures, traumatic injuries, or in various medical conditions by promoting coagulation or providing a mechanical barrier. The global hemostats market growth is principally driven by an escalating volume of surgical interventions worldwide, a progressively aging global population prone to various chronic diseases requiring surgical treatment, and the rising incidence of trauma cases.

Key Market Drivers

The Global Hemostats Market is significantly influenced by the confluence of a growing geriatric population and continuous advancements in hemostatic technologies. The increasing proportion of older adults globally represents a substantial and expanding patient demographic requiring surgical intervention. This demographic often presents with multiple comorbidities, necessitating more frequent and complex procedures where effective bleeding control is paramount. For instance, according to a study highlighted by ResearchGate in August 2025, older individuals typically require surgical procedures four times more often than the younger population, directly increasing the demand for hemostatic agents during these interventions.

Key Market Challenges

The stringent and complex regulatory approval processes represent a significant impediment to the growth of the Global Hemostats Market. These rigorous requirements necessitate protracted development timelines and substantially increased costs for manufacturers. Such an environment diverts significant financial and human capital towards compliance rather than innovation, thereby slowing the introduction of novel hemostatic solutions to address unmet clinical needs.

Key Market Trends

The expanding adoption of minimally invasive surgical approaches significantly influences the global hemostats market by creating demand for specialized bleeding control solutions. These techniques, favored for enhanced patient recovery and reduced hospital stays, are increasingly applied across diverse surgical disciplines. According to the National Institutes of Health, over 1 million hip and knee arthroplasty procedures were performed annually in the U. S. in 2024, a large volume where minimally invasive techniques are increasingly utilized. This procedural shift necessitates hemostatic agents that are effective and precisely applicable within constricted surgical fields.

Key Market Players

• Johnson & Johnson
• Baxter International Inc.
• Pfizer Inc
• B Braun Medical Inc
• Becton, Dickinson, and Company
• Teleflex Incorporated
• Medtronic Plc
• Hemostasis, LLC
• Stryker Corporation
• Integra LifeSciences Corporation

Report Scope:

In this report, the Global Hemostats Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Hemostats Market, By Type:

• Thrombin-based Hemostats
• Oxidized Regenerated Cellulose-based Hemostats
• Combination Hemostats
• Gelatin-based Hemostats
• Collagen-based Hemostats
• Other Hemostats

Hemostats Market, By Formulation:

• Matrix & Gel Hemostats
• Sheet & Pad Hemostats
• Sponge Hemostats
• Powder Hemostats

Hemostats Market, By Application:

• Orthopedic Surgery
• General Surgery
• Neurological Surgery
• Cardiovascular Surgery
• Reconstructive Surgery
• Gynecological Surgery
• Other Surgical Applications

Hemostats Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Hemostats Market.

Available Customizations:

Global Hemostats Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hemostats Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Thrombin-based Hemostats, Oxidized Regenerated Cellulose-based Hemostats, Combination Hemostats, Gelatin-based Hemostats, Collagen-based Hemostats, Other Hemostats)
  • 5.2.2. By Formulation (Matrix & Gel Hemostats, Sheet & Pad Hemostats, Sponge Hemostats, Powder Hemostats)
  • 5.2.3. By Application (Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Reconstructive Surgery, Gynecological Surgery, Other Surgical Applications)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Market Map

6. North America Hemostats Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type
  • 6.2.2. By Formulation
  • 6.2.3. By Application
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Hemostats Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Formulation
      • 6.3.1.2.3. By Application
  • 6.3.2. Canada Hemostats Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Formulation
      • 6.3.2.2.3. By Application
  • 6.3.3. Mexico Hemostats Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Formulation
      • 6.3.3.2.3. By Application

7. Europe Hemostats Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type
  • 7.2.2. By Formulation
  • 7.2.3. By Application
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Hemostats Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Formulation
      • 7.3.1.2.3. By Application
  • 7.3.2. France Hemostats Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Formulation
      • 7.3.2.2.3. By Application
  • 7.3.3. United Kingdom Hemostats Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Formulation
      • 7.3.3.2.3. By Application
  • 7.3.4. Italy Hemostats Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Formulation
      • 7.3.4.2.3. By Application
  • 7.3.5. Spain Hemostats Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Formulation
      • 7.3.5.2.3. By Application

8. Asia Pacific Hemostats Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type
  • 8.2.2. By Formulation
  • 8.2.3. By Application
  • 8.2.4. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Hemostats Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Formulation
      • 8.3.1.2.3. By Application
  • 8.3.2. India Hemostats Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Formulation
      • 8.3.2.2.3. By Application
  • 8.3.3. Japan Hemostats Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Formulation
      • 8.3.3.2.3. By Application
  • 8.3.4. South Korea Hemostats Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Formulation
      • 8.3.4.2.3. By Application
  • 8.3.5. Australia Hemostats Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Formulation
      • 8.3.5.2.3. By Application

9. Middle East & Africa Hemostats Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type
  • 9.2.2. By Formulation
  • 9.2.3. By Application
  • 9.2.4. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Hemostats Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Formulation
      • 9.3.1.2.3. By Application
  • 9.3.2. UAE Hemostats Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Formulation
      • 9.3.2.2.3. By Application
  • 9.3.3. South Africa Hemostats Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Formulation
      • 9.3.3.2.3. By Application

10. South America Hemostats Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type
  • 10.2.2. By Formulation
  • 10.2.3. By Application
  • 10.2.4. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Hemostats Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Formulation
      • 10.3.1.2.3. By Application
  • 10.3.2. Colombia Hemostats Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Formulation
      • 10.3.2.2.3. By Application
  • 10.3.3. Argentina Hemostats Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Formulation
      • 10.3.3.2.3. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Hemostats Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Johnson & Johnson
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Baxter International Inc.
• 15.3. Pfizer Inc
• 15.4. B Braun Medical Inc
• 15.5. Becton, Dickinson, and Company
• 15.6. Teleflex Incorporated
• 15.7. Medtronic Plc
• 15.8. Hemostasis, LLC
• 15.9. Stryker Corporation
• 15.10. Integra LifeSciences Corporation

16. Strategic Recommendations

17. About Us & Disclaimer